
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
They died 'doing what they loved': The stories of workers in their 80s who died on the job - 2
From Amateur to Master: My Involvement in Photography - 3
A Manual for Well known Western television Series - 4
Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals - 5
Dick Van Dyke shares his secrets to longevity as he turns 100
Manual for Tracking down Spending plan Agreeable Travel Objections
Nature's Treats: 10 Organic products That Lift Prosperity
Manual for Tracking down the Nearby Business sectors and Marketplaces
Why doing good also makes us feel good, during the holidays and beyond
Step by step instructions to Prepare with Senior Protection for Inward feeling of harmony.
Figure out how to Team up with Your Auto Crash Legal advisor for Best Outcomes
Hilary Duff announces new album ‘Luck… or Something,’ her first in over 10 years: ‘Excited is the largest understatement’
Working out at the airport? Some fliers can already smell the sweat.
Wizz CEO: We’re going to invest $1 b. in Israeli market













